Exposure of lymphocytes to high doses of Actinobacillus actinomycetemcomitans cytolethal distending toxin induces rapid onset of apoptosis-mediated DNA fragmentation

Infection and Immunity

Volumn 74, Issue 4, 2006, Pages 2080-2092

  Shenker, Bruce J ^a   Demuth, Donald R ^a   Zekavat, Ali ^a  

^a UNIVERSITY OF PENNSYLVANIA SCHOOL OF DENTAL MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZYLOXYCARBONYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; BROXURIDINE; CASPASE 3 INHIBITOR; CYTOLETHAL DISTENDING TOXIN; DNA FRAGMENT; HISTONE H2AX; PROTEIN BCL 2;

ACTINOBACILLUS ACTINOMYCETEMCOMITANS; APOPTOSIS; ARTICLE; CELL COUNT; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CONTROLLED STUDY; DNA STRAND BREAKAGE; DNA SYNTHESIS; DOSE RESPONSE; FLUORESCENCE ACTIVATED CELL SORTING; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; KINETICS; LEUKEMIA CELL LINE; LYMPHOCYTE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ACTINOBACILLUS ACTINOMYCETEMCOMITANS; APOPTOSIS; BACTERIAL TOXINS; CELL CYCLE; DNA FRAGMENTATION; HUMANS; JURKAT CELLS; KINETICS; LYMPHOCYTE ACTIVATION; LYMPHOCYTES;

EID: 33645515720     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.74.4.2080-2092.2006     Document Type: Article

References (50)

1. Castedo, M., A. Macho, N. Zamzami, T. Hirsch, P. Marchetti, J. Uriel, and G. Kroemer. 1995. Mitochondrial perturbations define lymphocytes undergoing apoptotic depletion in vivo. Eur. J. Immunol. 25:3277-3284.
2. Chiou, S.-K., L. Rao, and E. White. 1994. Bcl-2 blocks p53-dependent apoptosis. Mol. Cell. Biol. 14:2556-2563.
3. 2/M transition by preventing Cdc2 protein kinase dephosphorylation and activation. Infect. Immun. 65:5088-5095.
4. Cope, L., S. L. J. Lumbley, J. Klesney-Tait, M. Stevens, L. Johnson, M. Purven, R. Munson, T. Lagergard, J. Radolf, and E. Hansen. 1997. A diffusible cytotoxin of Haemophilus ducreyi. Proc. Natl. Acad. Sci. USA 94:4056-4061.
5. Cortes-Bratti, X., E. Chaves-Olarte, T. Lagergard, and M. Thelastam. 2000. Cellular internalization of cytolethal distending toxin from Haemophilus ducreyi. Infect. Immun. 68:6903-6911.
6. Cortes-Bratti, X., E. Chaves-Olarte, T. Lagergard, and S. Thiagalingam. 1999. The cytolethal distending toxin from the chancroid bacterium Haemophilus ducreyi induces cell cycle arrest in the G2 phase. J. Clin. Investig. 103:107-115.
7. Cortes-Bratti, X., C. Karlsson, T. Lagergard, M. Thelastam, and T. Frisan. 2001. The Haemophilus ducreyi cytolethal distending toxin induces cell cycle arrest and apoptosis via the DNA damage checkpoint pathways. J. Biol. Chem. 276:5296-5302.
8. Darzynkiewicz, Z., G. Juan, X. Li, W. Gorczyca, T. Murakami, and F. Traganos. 1997. Cytometry in cell necrobiology: analysis of apoptosis and accidental cell death (necrosis). Cytometry 27:1-20.
9. De Rycke, J., and E. Oswald. 2001. Cytolethal distending toxin (CDT): a bacterial weapon to control host cell proliferation? FEMS Microbiol. Lett. 203:141-148.
10. Elwell, C. A., K. Chao, K. Patel, and L. A. Dreyfus. 2001. Escherichia coli CdtB mediates cytolethal distending toxin cell cycle arrest. Infect. Immun. 69:3418-3422.
11. Elwell, C. A., and L. A. Dreyfus. 2000. DNase I homologous residues in CdtB are critical for cytolethal distending toxin-mediated cell cycle arrest. Mol. Microbiol. 37:952-963.
12. Frisan, T., X. Cortes-Bratti, E. Chaves-Olarte, B. Stenerlow, and M. Thelastam. 2003. The Haemophilus ducreyi cytolethal distending toxin induces DNA double-strand breaks and promotes ATM-dependent activation of RhoA. Cell Microbiol. 5:695-707.
13. Frisk, A., M. Lebens, C. Johansson, H. Ahmed, L. Svensson, K. Ahlman, and T. Lagergard. 2001. The role of different protein components from the Haemophilus ducreyi cytolethal distending toxin in the generation of cell toxicity. Microb. Pathog. 30:313-324.
14. Gelfanova, V., E. Hansen, and S. Spinola. 1999. Cytolethal distending toxin of Haemophilus ducreyi induces apoptotic death of Jurkat T cells. Infect. Immun. 67:6394-6402.
15. Golstein, P. 1997. Controlling cell death. Science 275:1081-1082.
16. Haghjoo, E., and J. E. Galan. 2004. Salmonella typhi encodes a functional cytolethal distending toxin that is delivered into host cells by a bacterial-internalization pathway. Proc. Natl. Acad. Sci. USA 101:4614-4619.
17. Herrmann, J. L., E. Bruckheimer, and T. J. McDonnell. 1996. Cell death signal transduction and Bcl-2 function. Biochem. Soc. Trans. 1059-1065.
18. Holubec, H., C. Payne, H. Bernstein, K. Dvorakova, C. Berstein, C. Waltmire, J. Warneke, and H. Garewal. 2005. Assessment of apoptosis by immunohistochemical markers compared to cellular morphology in ex vivo-stressed colonic mucosa. J. Histol. Cytol. 53:229-235.
19. InSug, O., S. Datar, C. J. Koch, I. M. Shapiro, and B. J. Shenker. 1997. Mercuric compounds inhibit human monocyte function by inducing apoptosis: evidence for formation of reactive oxygen species, development of mitochondrial membrane permeability transition and loss of reductive reserve. Toxicology 124:211-224.
20. 2 + M phase of the cell cycle. J. Virol. 69:6304-6313.
21. Kluck, R. M., E. Bossy-Wetzel, D. R. Green, and D. D. Newmeyer. 1997. The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science 275:1132-1136.
22. Kobayashi, J. 2004. Molecular mechanism of the recruitment of NBS1/hMRE11/HRAD50 complex to DNA double-strand breaks: NBS1 binds to g-H2Ax through FHA/BRCT domain. J. Radiat. Res. 45:473-478.
23. Kroemer, G. 1997. The proto-oncogene Bcl-2 and its role in regulating apoptosis. Nat. Med. 3:614-620.
24. Lara-Tejero, M., and J. E. Galan. 2001. CdtA, CdtB, and CdtC form a tripartite complex that is required for cytolethal distending toxin activity. Infect. Immun. 69:4358-4365.
25. Lara-Tejero, M., and J. E. Galan. 2000. A bacterial toxin that controls cell cycle progression as a deoxyribonuclease I-like protein. Science 290:354-357.
26. Lee, W., L. Pankoski, A. Zekavat, and B. J. Shenker. 2004. Treponema denticola immunoinhibitory protein induces irreversible G1 arrest in activated human lymphocytes. Oral Microbiol. Immunol. 19:144-149.
27. Lowndes, N., and G. Toh. 2005. DNA repair: the importance of phosphorylating histone H2AX. Curr. Biol. 15:R99-R102.
28. 2/M phase transition of the mammalian cell cycle. Proc. Natl. Acad. Sci. USA 95:3419-3424.
29. Mao, X., and J. M. DiRienzo. 2002. Functional studies of the recombinant subunits of a cytolethal distending toxin. Cell. Microbiol. 4:245-255.
30. Mayer, M., L. Bueno, E. Hansen, and J. M. DiRienzo. 1999. Identification of a cytolethal distending toxin gene locus and features of a virulence-associated region in Actinobacillus actinomycetemcomitans. Infect. Immun. 67:1227-1237.
31. McSweeney, L., and L. A. Dreyfus. 2004. Nuclear localization of the Escherichia coli cytolethal distending toxin CdtB subunit. Cell. Microbiol. 6:447-458.
32. Nalbant, A., C. Chen, Y. Wang, and H. H. Zadeh. 2003. Induction of T-cell apoptosis by Actinobacillus actinomycetemcomitans mutants with deletion of ltxA and cdtABC genes: possible activity of GroEL-like molecule. Oral Microbiol. Immunol. 18:339-349.
33. Nesic, D., Y. Hsu, and C. E. Stebbins. 2004. Assembly and function of a bacterial genotoxin. Nature 429:429-433.
34. Ohara, M., T. Hayashi, Y. Kusonoki, M. Miyauchi, T. Takata, and M. Sugai. 2004. Caspase-2 and caspase-7 are involved in cytolethal distending toxin-induced apoptosis in Jurkat and MOLT-4 T-cell lines. Infect. Immun. 74:871-879.
35. 2/M phase and apoptosis. Infect. Immun. 66:5980-5987.
36. Okuda, J., M. Fukumoto, Y. Takeda, and M. Nishibuchi. 1997. Examination of diarrheagenicity of cytolethal distending toxin: suckling mouse response to the products of the cdtABC genes of Shigella dysenteriae. Infect. Immun. 65:428-433.
37. Okuda, J., H. Kurazono, and Y. Takeda. 1995. Distribution of the cytolethal distending toxin A gene (cdtA) among species of Shigella and Vibrio, and cloning and sequencing of the cdt gene from Shigella dysenteriae. Microb. Pathog. 18:167-172.
38. Peres, S. Y., O. Marches, F. Daigle, J. P. Nougayrede, F. Herault, C. Tasca, J. De Rycke, and E. Oswald. 1997. A new cytolethal distending toxin (CDT) from Escherichia coli producing CNF2 blocks HeLa cell division in G2/M phase. Mol. Microbiol. 24:1095-1107.
39. Pickett, C. L., D. L. Cottle, E. C. Pesci, and G. Bikah. 1994. Cloning, sequencing, and expression of the Escherichia coli cytolethal distending toxin genes. Infect. Immun. 62:1046-1051.
40. Pickett, C. L., and C. A. Whitehouse. 1999. The cytolethal distending toxin family. Trends Microbiol. 7:292-297.
41. Scott, D. A., and J. B. Kaper. 1994. Cloning and sequencing of the genes encoding Escherichia coli cytolethal distending toxin. Infect. Immun. 62:244-251.
42. Sert, V., C. Cans, C. Tasca, L. Bret-Bennis, E. Oswald, B. Ducommun, and J. De Rycke. 1999. The bacterial cytolethal distending toxin (CDT) triggers a G2 cell cycle checkpoint in mammalian cells without preliminary induction of DNA strand breaks. Oncogene 18:6296-6304.
43. Shenker, B. J., D. Besack, T. L. McKay, L. Pankoski, A. Zekavat, and D. R. Demuth. 2004. Actinobacillus actinomycetemcomitans cytolethal distending toxin (Cdt): evidence that the holotoxin is composed of three subunits: CdtA, CdtB, and CdtC. J. Immunol. 172:410-417.
44. Shenker, B. J., D. Besack, T. L. McKay, L. Pankoski, A. Zekavat, and D. R. Demuth. 2005. Induction of cell cycle arrest in lymphocytes by Actinobacillus actinomycetemcomitans cytolethal distending toxin requires three subunits for maximum activity. J. Immunol. 174:2228-2234.
45. 1 phase of the cell cycle. Infect. Immun. 63:4830-4836.
46. Shenker, B. J., R. H. Hoffmaster, T. L. McKay, and D. R. Demuth. 2000. Expression of the cytolethal distending toxin (Cdt) operon in Actinobacillus actinomycetemcomitans: evidence that the CdtB protein is responsible for G2 arrest of the cell cycle in human T-cells. J. Immunol. 165:2612-2618.
47. 2 arrest of the cell cycle. J. Immunol. 167:435-441.
48. 1 to S transition in AGS gastric epithelial cells. Cancer Res. 59:2277-2281.
49. Thelastam, M., and T. Frisan. 2004. Cytolethal distending toxins. Rev. Physiol. Biochem. Pharmacol. 152:111-133.
50. 2-phase cell cycle block. Infect. Immun. 66:1934-1940.